Post-Marketing Withdrawal Of Medicines Because of Adverse Drug Reactions: An Analysis of Anti-Obesity Medications

被引：0
|
作者：
Onakpoya, I. [1 ]
Heneghan, C. [1 ]
Aronson, J. [1 ]
机构：
[1] Univ Oxford, Primary Care Hlth Sci, Oxford, England
来源：
DRUG SAFETY | 2015年 / 38卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
P 127
引用
收藏
页码：1016 / 1017
页数：2
相关论文
共 50 条
  • [41] Advancing drug safety science by integrating molecular knowledge with post-marketing adverse event reports
    Soldatos, Theodoros G.
    Kim, Sarah
    Schmidt, Stephan
    Lesko, Lawrence J.
    Jackson, David B.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2022, 11 (05): : 540 - 555
  • [42] Reduced absorption of lipophilic anti-epileptic medications when used concomitantly with the anti-obesity drug orlistat
    Bigham, Sarah
    McGuigan, Christopher
    MacDonald, Bridget K.
    EPILEPSIA, 2006, 47 (12) : 2207 - 2207
  • [43] What Is the Safety Profile of Cannabis-Based Medications? Analysis of the Post-Marketing Signals from the FDA Adverse Event Reporting System
    Lunghi, C.
    Fusaroli, M.
    Giunchi, V.
    Raschi, E.
    Zongo, A.
    Poluzzi, E.
    DRUG SAFETY, 2022, 45 (10) : 1242 - 1243
  • [44] A Pharmacovigilance Approach for Post-Marketing in Japan Using the Japanese Adverse Drug Event Report (JADER) Database and Association Analysis
    Fujiwara, Masakazu
    Kawasaki, Yohei
    Yamada, Hiroshi
    PLOS ONE, 2016, 11 (04):
  • [45] Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013–2020
    Abdulrahman Alsuhibani
    Marwan Alrasheed
    Musaab Gari
    Ana L. Hincapie
    Jeff Jianfei Guo
    International Journal of Clinical Pharmacy, 2022, 44 : 172 - 179
  • [46] Utilization of Anti-obesity Medications After Bariatric Surgery: Analysis of a Large National Database
    Firkins, Stephen A.
    Chittajallu, Vibhu
    Flora, Bailey
    Yoo, Heesoo
    Simons-Linares, Roberto
    OBESITY SURGERY, 2024, 34 (05) : 1415 - 1424
  • [47] Utilization of Anti-obesity Medications After Bariatric Surgery: Analysis of a Large National Database
    Stephen A. Firkins
    Vibhu Chittajallu
    Bailey Flora
    Heesoo Yoo
    Roberto Simons-Linares
    Obesity Surgery, 2024, 34 : 1415 - 1424
  • [48] UTILIZATION OF ANTI-OBESITY MEDICATIONS AFTER BARIATRIC SURGERY: ANALYSIS OF A LARGE NATIONAL DATABASE
    Firkins, Stephen
    Chittajallu, Vibhu
    Yoo, Heesoo
    Abu Omar, Yazan
    Flora, Bailey
    Simons-Linares, C. Roberto
    GASTROENTEROLOGY, 2023, 164 (06) : S179 - S179
  • [49] Post-marketing safety of finerenone: a disproportionality analysis of the FDA adverse event reporting system
    Jin, Yiyi
    Fan, Miao
    Zheng, Xiaomeng
    Zhu, Suyan
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [50] Safety of Bempedoic Acid: Post-marketing Analysis of the FDA Adverse Event Reporting System
    Raschi, E.
    Fusaroli, M.
    Forni, M.
    Goldman, A.
    Cicero, A. F. G.
    Poluzzi, E.
    Ponti, F. D.
    DRUG SAFETY, 2022, 45 (10) : 1287 - 1288
12345